- Home
- BNTX vs ROL Comparison
BNTX vs ROL Comparison
Compare BNTX & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- ROL
- Stock Information
- Founded
- BNTX 2008
- ROL 1948
- Country
- BNTX Germany
- ROL United States
- Employees
- BNTX N/A
- ROL N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- ROL Diversified Commercial Services
- Sector
- BNTX Health Care
- ROL Finance
- Exchange
- BNTX Nasdaq
- ROL Nasdaq
- Market Cap
- BNTX 23.9B
- ROL 23.9B
- IPO Year
- BNTX 2019
- ROL N/A
- Fundamental
- Price
- BNTX $114.13
- ROL $46.60
- Analyst Decision
- BNTX Strong Buy
- ROL Buy
- Analyst Count
- BNTX 15
- ROL 6
- Target Price
- BNTX $143.50
- ROL $51.00
- AVG Volume (30 Days)
- BNTX 659.5K
- ROL 1.7M
- Earning Date
- BNTX 11-04-2024
- ROL 02-12-2025
- Dividend Yield
- BNTX N/A
- ROL 1.42%
- EPS Growth
- BNTX N/A
- ROL 16.84
- EPS
- BNTX N/A
- ROL 0.97
- Revenue
- BNTX $3,390,698,192.00
- ROL $3,310,625,000.00
- Revenue This Year
- BNTX N/A
- ROL $10.99
- Revenue Next Year
- BNTX N/A
- ROL $8.38
- P/E Ratio
- BNTX N/A
- ROL $48.05
- Revenue Growth
- BNTX N/A
- ROL 11.07
- 52 Week Low
- BNTX $76.53
- ROL $40.41
- 52 Week High
- BNTX $131.49
- ROL $52.16
- Technical
- Relative Strength Index (RSI)
- BNTX 49.15
- ROL 30.04
- Support Level
- BNTX $109.52
- ROL $46.18
- Resistance Level
- BNTX $115.34
- ROL $49.69
- Average True Range (ATR)
- BNTX 4.74
- ROL 0.77
- MACD
- BNTX -0.80
- ROL -0.30
- Stochastic Oscillator
- BNTX 29.03
- ROL 11.70
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About ROL Rollins Inc.
Rollins is a global leader in route-based pest-control services, with operations spanning North, Central and South America, Europe, the Middle East and Africa and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, market leader in the US, where it boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on US and Canadian markets.